DA-EPOCH-R in MYC-rearranged DLBCL has been investigated in a phase II trial of 53 patients (19 isolated MYC rearrangement; 24 MYC and BCL2 and/or BCL6 rearrangement). This evidence concerns the gene MYC and diffuse large B-cell lymphoma.